Form 4 for IDXX Idexx Laboratories
Accepted 2022-08-08 00:00:00 ET · period of report 2022-08-05 · accession 0001567619-22-015173 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-08 | 2022-08-05 | IDXX | MAZELSKY JONATHAN JAY | Pres, CEO, Dir | M - OptEx | $0.00 | +385 | 51.7K | +0.8% | $0 |
| D | 2022-08-08 | 2022-08-05 | IDXX | MAZELSKY JONATHAN JAY | Pres, CEO, Dir | F - Tax | $407.78 | -179 | 51.5K | -0.3% | -$73.0K |
| D | 2022-08-08 | 2022-08-05 | IDXX | MAZELSKY JONATHAN JAY | Pres, CEO, Dir | M - OptEx | — | -385 | 9,990 | -4% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-05 | M | A | 385 | $0.00 | 51,696.64 | D | — | — | (F1) Includes 11 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2022. |
| 2 | Common | Common Stock | 2022-08-05 | F | D | 179 | $407.78 | 51,517.64 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2022-08-05 | M | D | 385 | — | 9,990 | D | — · — to — | 385 Common Stock | (F3) Not applicable. (F2) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020. |